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Toby Seddon’s starting point in this authoritative analysis of the ‘drug problem’ is to 
understand its contemporary formulation by adopting a historical analysis that focuses upon 
changing paradigms of governance.  Central to his argument is the relationship between the 
regulation of drugs and conceptions of freedom, which are mediated by changing notions of 
the will under different manifestations of liberalism. Addiction, it is argued, is a governmental 
concept that has made possible the assembling of particular strategies and practices to 
govern human conduct. Seddon bases his analysis around three pieces of legislation 
(discussed below) which, he argues, are particularly significant in terms of illustrating how 
the drug problem has been imagined and regulated. Despite being a relatively slim volume, 
A History of Drugs is rich in detail and sophisticated analysis, drawing upon the works of 
Foucault, Garland and Braithwaite, among others, to depict the ‘drug problem’ in historical 
perspective as a ‘multi-layered mosaic’.   
Seddon’s historical analysis takes as its first focus the Pharmacy Act of 1868 which 
contained the first attempts to legislate for the use of ‘poisons’, including opium. He observes 
that, while alcohol use was an increasing social concern in the 19th century, the use of opium 
was commonplace and opium and opiates were regarded as commodities in the liberal 
market economy. Public health approaches developed during that century as a response to 
the health concerns brought about by increasing industrialisation and urbanisation. The 
emergence of the Foucauldian concept of ‘population’ and statistical information, Seddon 
argues, enabled social problems to become visible and governable, with public health 
becoming part of a liberal technology to respond to newly visible heath problems. Alongside 
these developments, the regulation of markets became more diffuse and fragmented, and 
the growth of liberal economic freedom was accompanied by an expanding regulatory 
framework of public health (which itself led to the later development of a ‘quasi collectivist’ 
welfare state), with medical professionals identified as the appropriate dispensers of drugs. 
The labelling (but not prohibition) of opium and opiates introduced by the Pharmacy Act was 
consistent with the classical liberal conception of freedom and the idea that opiate use was a 
vice rather than a disease: thus the legislation was aimed at addressing the growing problem 
of (accidental and suicidal) opium poisoning. While alcohol was increasingly viewed as out of 
control, compulsive behaviour – and this was linked to the growth of the temperance 
movement - he fact that opium was not associated with the concept of ‘addition’  enabled the 
application of a regulatory light touch.  
By the time the Dangerous Drugs Act of 1920 was introduced, our contemporary concept of 
drug had been established and a clear regulatory divide had emerged with respect to drugs 
and alcohol. As the mode of government became increasingly interventionist during the late 
19th century and the proliferation of regulatory branches provided increasing sites for 
intervention, people were increasingly viewed as social citizens - free-willed, autonomous 
actors with responsibilities towards themselves and their families - and new powers were 
introduced to ‘normalize’ those who were failing to meet these responsibilities. Seddon 
argues that addiction increasingly became regarded as a ‘disease of the will’ and, hence, 
both a moral failing and a physical disease while ‘inebriety’ was associated with 
degeneration that threatened to weaken the racial stock. Alongside these domestic 
concerns, globalisation made possible the establishment in the early 20th century of an 
international drug control system that culminated in the UK in the 1920 Dangerous Drugs Act  
that aimed to restrict the use of opium, opiates and cocaine for medical purposes. The 1926 
Rolleston Report subsequently established the ‘British System’ in which these substances 
could also be prescribed to those who required gradual withdrawal or who could not 
completely withdraw. This, Seddon suggests, represented an accommodation between 
penal and medical approaches that resonates with Garland’s analysis of the transfer to 
welfare liberalism. 
The third piece of legislation which is argued to be significant in terms of how the drug 
problem is imagined and regulated is the Drugs Act of 2005 which introduced a number of 
provisions aimed at expanding and strengthening measures that were already in place as 
part of the Drug Interventions Programme.  Seddon argues, however, that although the most 
recent trend towards dealing with drug use as a criminal justice issue could be regarded as 
one of several distinctive phases in how the drug problem is conceptualised and regulated, 
the emergence of risk discourses associated with neo-liberalism can provide a unifying 
framework for understanding apparently diverse approaches to the drug problem from the 
1960s onwards. During this period, the notion of ‘problem drug use’ gained prominence, 
referring to the problems experienced by drug users and, increasingly, the problems that 
drug use caused to others. Drug use was thus recast as a threat to the wider community that 
needed to be monitored and controlled.  Particular concerns centred upon the threat posed 
by HIV/AIDS in the 1980s and the increase in drug-related property crime. With an emphasis 
upon the potential harm to the self or others, risk, according to Seddon, became a key 
organising principle for attempts to deal with the drug problem. Within such a risk discourse, 
drug users were viewed as capable of, and urged to make, responsible, albeit constrained, 
choices about their consumption practices. Seddon argues that rather than being a distinct 
and unrelated development, harm reduction emerged in the context of a public health 
approach associated with HIV/AIDS, in parallel with new criminal justice initiatives that aimed 
to address drug-related crime. Both developments are underpinned, he suggests, by the 
construction of the drug user as a threat who needs to be encouraged to act prudentially and 
responsibly. In further developing this argument, Seddon draws upon Bauman’s notion of 
‘flawed consumers – which he terms ‘disordered consumption - ’ to account for increasing 
unease associated with a growing focus on the risks associated with drug consumption. 
Such a focus on risk, he suggests, cuts across substances to provide a unifying perspective 
on the ‘problem’ of drugs. 
Having set out his historical analysis of the drug problem, and highlighted its continuities and 
discontinuities, Seddon turns to a consideration of how it might be re-framed as a regulatory 
and governance challenge. Here he draws principally on Braithwaite’s work on regulation, 
Shearing’s work on nodal governance and the global administrative law approach to global 
governance. His intention is not to set out a programme of action but, rather, to identify an 
agenda for research and development in which the regulatory map for the ‘drug problem’ can 
be redrawn. Brathwaite’s design principles for flipping market from vice to virtue offers a 
theory of transition involving a process of concrete incremental change with its basis in 
evidence based democratic incrementalism. More specifically, the concept of regulatory 
pyramids can provide a new, and more parsimonious, way of thinking about how to regulate 
drugs with its emphasis upon knowledge based compliance combined with strategies aimed 
at promoting self regulation (meta-regulation). The concept of nodal governance, on the 
other hand, by taking as its starting point the central importance of knowledge and 
information for governance where the management of events operates within and across 
networks, can be applied to the drug problem through the nodal mapping of system 
governance and through experimentation with micro governance strategies for ‘weak’ actors: 
the latter, for instance, offers a mechanism through which communities with drug problems 
could participate in a process of ‘democratic experimentalism’. Finally, the global 
governance approach, which acknowledges governance as a complex phenomenon with 
multiple actors operating at multiple levels with multiple purposes and sources of authority, 
offers a further basis for a mapping exercise to examine how, for example, non-criminal 
measures could be used in drug control. 
In the introductory chapter the author indicates that the aim of the book is to offer a critical 
analysis that challenges current thinking about the problem of drugs. It does this by 
highlighting the multiple strands that have shaped how the drug problem has been imagined 
and regulated since it first ‘emerged’ and how these can be understood through their 
relationship to the differing conceptions of freedom associated with changing forms of liberal 
governance. Anyone who is seeking to understand how to address the current ‘drug 
problem’ will be disappointed because Seddon’s book does not, in this sense, offer any 
‘answers’. But it does not set out to do this. Instead, it is a thoughtful, authoritative and 
skilfully developed thesis that underlines the limitations of analysing a social problem without 
use of broader historical and theoretical perspectives.  Moreover, by reframing the drug 
problem as a regulatory and governance challenge, Toby Seddon sets out an alluring, if 
somewhat daunting, agenda for future policy and research. 
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